DCM
Driehaus Capital Management Portfolio holdings
AUM
$12.5B
1-Year Return
79.21%
This Quarter Return
+15.96%
1 Year Return
+79.21%
3 Year Return
+526.69%
5 Year Return
+1,716.36%
10 Year Return
+17,720.68%
AUM
$6.71B
AUM Growth
+$103M
(+1.6%)
Cap. Flow
-$161M
Cap. Flow
% of AUM
-2.39%
Top 10 Holdings %
Top 10 Hldgs %
17.84%
Holding
435
New
92
Increased
114
Reduced
130
Closed
88
Top Buys
| 1 |
Credicorp
BAP
|
$48.5M |
| 2 |
Fabrinet
FN
|
$41.7M |
| 3 |
ASML
ASML
|
$39.1M |
| 4 |
ABCM
Abcam plc American Depositary Shares
ABCM
|
$37.8M |
| 5 |
Array Technologies
ARRY
|
$36.8M |
Top Sells
| 1 |
Cameco
CCJ
|
$70.8M |
| 2 |
Lantheus
LNTH
|
$68.7M |
| 3 |
EPAM Systems
EPAM
|
$62.9M |
| 4 |
Cytokinetics
CYTK
|
$56.8M |
| 5 |
Palomar
PLMR
|
$45.1M |
Sector Composition
| 1 | Technology | 24.88% |
| 2 | Healthcare | 21.89% |
| 3 | Industrials | 17.41% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Financials | 7.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Alphabet (Google) Class A
GOOGL
$2.84T
| $270K | ﹤0.01% |
3,060
-56
| -2% | -$4.94K |
|
327
VICI Properties
VICI
$35.8B
| $270K | ﹤0.01% |
+8,321
| New | +$270K |
|
328
Genuine Parts
GPC
$19.4B
| $264K | ﹤0.01% |
1,521
-222
| -13% | -$38.5K |
|
329
LPL Financial
LPLA
$26.6B
| $261K | ﹤0.01% |
1,208
-42,301
| -97% | -$9.14M |
|
330
KKR & Co
KKR
$121B
| $255K | ﹤0.01% |
5,492
+198
| +4% | +$9.19K |
|
331
Accenture
ACN
$159B
| $253K | ﹤0.01% |
950
-28
| -3% | -$7.47K |
|
332
Thermo Fisher Scientific
TMO
$186B
| $245K | ﹤0.01% |
444
-22
| -5% | -$12.1K |
|
333
HP
HPQ
$27.4B
| $241K | ﹤0.01% |
8,970
-482
| -5% | -$13K |
|
334
Regions Financial
RF
$24.1B
| $237K | ﹤0.01% |
+10,970
| New | +$237K |
|
335
Prologis
PLD
$105B
| $229K | ﹤0.01% |
2,034
-62
| -3% | -$6.99K |
|
336
Danaher
DHR
$143B
| $223K | ﹤0.01% |
949
-53
| -5% | -$12.5K |
|
337
Apollo Global Management
APO
$75.3B
| $222K | ﹤0.01% |
3,484
-1,814
| -34% | -$116K |
|
338
Boyd Gaming
BYD
$6.93B
| $221K | ﹤0.01% |
+4,055
| New | +$221K |
|
339
Arthur J. Gallagher & Co
AJG
$76.7B
| $214K | ﹤0.01% |
+1,133
| New | +$214K |
|
340
National Fuel Gas
NFG
$7.82B
| $209K | ﹤0.01% |
+3,300
| New | +$209K |
|
341
Bristol-Myers Squibb
BMY
$96B
| $206K | ﹤0.01% |
+2,862
| New | +$206K |
|
342
Macy's
M
$4.64B
| $204K | ﹤0.01% |
+9,895
| New | +$204K |
|
343
Targa Resources
TRGP
$34.9B
| $203K | ﹤0.01% |
+2,760
| New | +$203K |
|
344
MGIC Investment
MTG
$6.55B
| $146K | ﹤0.01% |
11,201
-439
| -4% | -$5.71K |
|
345
Inotiv
NOTV
$56.3M
| $124K | ﹤0.01% |
25,000
| – | – |
|
346
Annexon
ANNX
$238M
| $6.22K | ﹤0.01% |
1,291,572
| – | – |
|
347
Archer Daniels Midland
ADM
$30.2B
| – | – |
-2,518
| Closed | -$203K |
|
348
Albemarle
ALB
$9.6B
| – | – |
-66,366
| Closed | -$17.6M |
|
349
Altimmune
ALT
$334M
| – | – |
-1,222,586
| Closed | -$15.6M |
|
350
AtriCure
ATRC
$1.76B
| – | – |
-131,955
| Closed | -$5.16M |
|